Received Feb 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
no additional adverse event; looking for 2nd dose at 51 years of age. Patient is coming later today with prescription from HCP; This spontaneous report was received from a pharmacist and refers to a an adult patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On an unknown date, at the age of 43, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) (strength,expiration date, lot #, route and site of administration were not reported) for prophylaxis. The patient was looking for the second dose at 51 years of age. The patient was about to come later on 25-FEB-2025 with a prescription (product prescribing issue). No additional adverse event was reported. Lot # is being requested and will be submitted if received.